RlapsRisk BC
CE-IVDR-cleared AI diagnostic test that predicts breast-cancer recurrence risk from routine pathology data, spun out of Owkin's diagnostics division.
Find alternatives to RlapsRisk BC
Sold to hospitals/labs as a clinical diagnostic test; no public per-test price -- clinical procurement, not self-serve. Whether a recurring free tier exists is not stated either way.
What it does
- Data analysis
Sources
- Pricing
-
Official documentation · 14 Sep 2026
Sold to hospitals/labs as a clinical diagnostic test; no public per-test price -- clinical procurement, not self-serve. Whether a recurring free tier exists is not stated either way.
- Description
- What it does
- Sold within
-
Own page confirmed via waiv.com's own nav (after correcting a domain error -- waiv.ai is an unrelated boat-GPS company, confirmed against the existing waiv company record's website field). CE-IVDR cleared and sold clinically, but no self-serve rate or public price list found.
- Name
- URL
Also from Waiv
-
BRCAura RUO Data service
Research-use-only AI test assessing BRCA-related genomic risk signatures from pathology data, sold to research institutions rather than clinical end users.
-
Destra Platform
Workflow platform that orchestrates Waiv's diagnostic tests within a lab's existing pathology workflow, handling sample intake, result delivery and reporting.
-
MSIntuit Suite Data service
Suite of AI diagnostic tests covering colorectal, endometrial and gastric cancer screening from pathology slides, marketed as one branded product line on Waiv's own site.
Something wrong here? Send a correction — quote this product id: waiv-rlapsrisk-bc.